Max Masucci
Stock Analyst at Roth MKM
(4.07)
# 1,711
Out of 4,690 analysts
165
Total ratings
44.6%
Success rate
9.7%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MASS 908 Devices | Maintained: Buy | $11 → $13 | $10.73 | +21.16% | 3 | Aug 12, 2026 | |
| BDSX Biodesix | Maintained: Buy | $32 | $26.83 | +19.27% | 9 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Maintained: Buy | $8 | $7.12 | +12.36% | 5 | Aug 6, 2026 | |
| XGN Exagen | Maintained: Buy | $8 → $9 | $7.39 | +21.79% | 5 | Aug 5, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $40 | $33.50 | +19.40% | 20 | Jul 31, 2026 | |
| BLFS BioLife Solutions | Maintained: Buy | $29 → $25 | $36.38 | n/a | 5 | Aug 9, 2023 | |
| BRKR Bruker | Maintained: Hold | $75 → $79 | $57.08 | n/a | 4 | Aug 4, 2023 | |
| RVTY Revvity | Maintained: Buy | $155 → $151 | $128.80 | n/a | 5 | Aug 2, 2023 | |
| GH Guardant Health | Maintained: Buy | $70 → $53 | $161.50 | n/a | 18 | Feb 24, 2023 | |
| CTKB Cytek Biosciences | Reiterated: Buy | $17 | $4.68 | n/a | 2 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $99 | $86.34 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $15 | $2.64 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.07 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.19 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.22 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $100 | $326.26 | n/a | 22 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.91 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $1.59 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.8857 | n/a | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.57 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.71 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $470 → $515 | $215.59 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $0.001 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
908 Devices
Aug 12, 2026
Maintained: Buy
Price Target: $11 → $13
Current: $10.73
Upside: +21.16%
Biodesix
Aug 6, 2026
Maintained: Buy
Price Target: $32
Current: $26.83
Upside: +19.27%
Alpha Teknova
Aug 6, 2026
Maintained: Buy
Price Target: $8
Current: $7.12
Upside: +12.36%
Exagen
Aug 5, 2026
Maintained: Buy
Price Target: $8 → $9
Current: $7.39
Upside: +21.79%
Castle Biosciences
Jul 31, 2026
Maintained: Buy
Price Target: $40
Current: $33.50
Upside: +19.40%
BioLife Solutions
Aug 9, 2023
Maintained: Buy
Price Target: $29 → $25
Current: $36.38
Upside: n/a
Bruker
Aug 4, 2023
Maintained: Hold
Price Target: $75 → $79
Current: $57.08
Upside: n/a
Revvity
Aug 2, 2023
Maintained: Buy
Price Target: $155 → $151
Current: $128.80
Upside: n/a
Guardant Health
Feb 24, 2023
Maintained: Buy
Price Target: $70 → $53
Current: $161.50
Upside: n/a
Cytek Biosciences
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $4.68
Upside: n/a
Nov 15, 2022
Maintained: Buy
Price Target: $5 → $99
Current: $86.34
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $18 → $15
Current: $2.64
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $17.07
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.19
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.22
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $110 → $100
Current: $326.26
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $1.91
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $32 → $39
Current: $1.59
Upside: n/a
Nov 2, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $0.8857
Upside: n/a
Oct 14, 2021
Maintained: Buy
Price Target: n/a
Current: $1.57
Upside: n/a
Oct 14, 2021
Maintained: Hold
Price Target: n/a
Current: $8.71
Upside: n/a
Jul 14, 2021
Maintained: Buy
Price Target: $470 → $515
Current: $215.59
Upside: n/a
May 6, 2021
Maintained: Buy
Price Target: $3.5
Current: $0.001
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a